A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.
A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Against the backdrop of aging, chronic diseases, and a growing population, the healthcare system is going through a vital transformation. Healthcare is simply becoming increasingly individual-centric.
9d
Hosted on MSNABT Stock Jumps 12% Since Q4 Earnings: Time to Invest in Abbott?Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...
A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
As the revolutionary Freestyle Chess Grand Slam 2025 gets underway on 7 February, we take a look at the players competing in the tournament. Also check out Freestyle Chess Grand Slam format, schedule ...
2 Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24 3 Dexcom ... A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
2 Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev ... of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technol Ther. 2018;20(3):197-206.
During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results